
Targeted HD Wipe Sampling with USP <800> Compliance – Safer Surfaces, Smarter Monitoring!
USP <800> states the following: Environmental wipe sampling for HD surface residue should be performed routinely (e.g., initially as a benchmark and at least every 6 months, or more often as needed, to verify containment).
SOME RECOMMENDED AREAS to be sampled:
- Front grille within the C-PEC
- Cart beside the C-PEC
- Passthrough
- Floor in front of the C-PEC
- Armrest of a patient treatment chair
HD Wipe Sampling
Groups of drugs | Limit of detection (ng per paper) |
---|---|
Group 1F fluorouracil |
2 |
Group 1M methotrexate |
1 |
Group 2 cytarabine dacarbazine DOXOrubicin epirubicin gemcitabine melphalan |
2.5 0.5 10 10 0.5 1 |
Group 3 cyclophosphamide DOCEtaxel etoposide ifosfamide irinotecan methotrexate PACLitaxel PEMEtrexed topotecan vinBLAStine vinCRIstine |
0.5 30 2 0.5 2 1 10 2 1 5 5 |
Group 4 Platins: (CISplatin, oxaliplatin, CARBOplatin) |
0.5 |
Group 5 All hazardous drugs in groups 1 to 4 |
0.5 |
- Contribute to the assessment of safe practices in the workplace.
- Evaluate potential HD exposure to staff (pharmacy, nursing, other personnel)
- Validate the effectiveness of decontamination procedures.
- Assess the level of compliance of current procedures.
Pricing
Select the group and multiply the price
by the number of swabs needed.
Group 1.............................Call for Pricing
Group 2, 3, or 4.................Call for Pricing
Group 5............................Call for Pricing
Sampling Kit..........INCLUDED FOR FREE